An observational study in Meningitis/Encephalitis, sponsored by QIAGEN Gaithersburg, Inc. Completed at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2025-04-16.
Sponsored by QIAGEN Gaithersburg, Inc (part of QIAGEN) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Meningitis with a site in United Kingdom — none open to participants now, 1 under way, none of them phase 3. Meningitis · United Kingdom.
Among the 24 studies in Meningitis with a site in United Kingdom, this one is one of 2 that started in 2021, is one of 8 observational ones, and was the 19th registered.
268 studies on the registry are indexed under Meningitis; 28 are open to participants now.
Browse Meningitis studies →None of the 24 studies in Meningitis with a site in United Kingdom is open now. The open studies under Meningitis, anywhere →
Of the 17 Meningitis studies recruiting now, 11 (65%) set no upper age limit and 6 (35%) stop at 75 or younger; 7 take children under 18; 2 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 4 · Phase 4 4
First in 2003; this study’s year is marked. 2 started in 2021.
This study's enrollment of 595 is above the median of 535 across 64 observational studies indexed under Meningitis.
Median enrollment 68 across the 16 interventional studies, 1,415 across the 8 observational. Of the 20 that completed or were terminated, 4 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 24 have an industry lead sponsor. The 10 most frequent:
This study is registered under QIAGEN Gaithersburg, Inc, one of the names counted as QIAGEN. Under that name alone:
QIAGEN Gaithersburg, Inc is the lead sponsor of 27 studies on the registry; 1 is open to participants now.
QIAGEN has 3 studies filed under Meningitis — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 24 studies in Meningitis with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Study for performance evaluation of the QIAstat-Dx® Meningitis/Encephalitis Panel in comparison with other chosen comparator methods.
This multicenter study aims to evaluate the performance of QIAstat-Dx Meningitis/Encephalitis (ME) Panel with another validated comparator method.
Subjects (adults and children) with signs and symptoms of meningitis and/or encephalitis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
sensitivity
positive percentage agreement
Time frame: 6 weeks
specificity
negative percentage agreement
Time frame: 6 weeks
Plan to share: No — all samples are residual and anonymized
No publications or documents are linked to this record.
Ran from Oct 2021 to primary completion in Dec 2021, 1 month.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.